Artelo Biosciences Inc at LD Micro Main Event Transcript
Our next presenter is Greg Gorgas with our Artelo Biosciences. Take it away.
Thank you very much, and thank you to everybody in attendance. It's great to be with you here at the LD Micro Main Event. I will be making some forward-looking statements today. We would ask everybody to please go to our artelobio.com, where all of our SEC filings can be found in links on the website.
Artelo Biosciences is a clinical-stage company. We're focused in on lipid-signaling modification. And aim to treat cancer, cancer supportive care, and other related serious diseases.
Five things I'd like to communicate with you today about. One, is that we have a novel drug pipeline, multiple assets in the clinic and pre-clinical stage; near-term milestones over the next 3, 6, and 12 months; billion-dollar market opportunities across our entire portfolio of assets. This is underpinned by a very robust patent estate, and it's led by a proven leadership team that knows what finished and good looks
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
